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Spleens (GPCMV) provides a useful model for studies of congenital CMV infection.
During characterization of the GPCMV genome sequence, we identiﬁed two types of strains in a virus stock
purchased from ATCC. One of them, GPCMV/del, lacks a 1.6 kb locus that positionally corresponds to murine
CMV (MCMV) M129–M133. Growth of GPCMV/del in cell culture was marginally better than that of the other
strain, GPCMV/full, which harbors the 1.6 kb locus. However, in animals infected intraperitoneally with virus
stocks containing both strains, GPCMV/full disseminated more efﬁciently than GPCMV/del, including 200-
fold greater viral load in salivary glands. Viral DNA, transcripts of the immediate-early 2 gene homolog, and
viral antigens were more abundant in animals infected with GPCMV/full than in those infected with GPCMV/
del. Although the observed phenomena have some similarity with the growth properties of MCMV strains
defective in mck-1/mck-2(M129/131) and those defective in sgg(M132), no M129–M132 homologs were
found in the 1.6 kb locus. Since one of the ORFs in the locus has a weak sequence similarity with HCMV
UL130, which relates to cell tropism, further studies will be required to learn the mechanism for efﬁcient
GPCMV growth in animal.
© 2008 Elsevier Inc. All rights reserved.IntroductionHuman cytomegalovirus (HCMV) is the most common cause of
congenital virus infection. Congenital infection occurs in 0.2–1% of all
births, and causes birth defects and developmental abnormalities
(Pass, 2001). Longitudinal studies of infants with asymptomatic
congenital HCMV infection at birth have revealed that 5–17% of them
develop progressive sensorineural hearing loss (SNHL) within a few
years of life (Fowler and Boppana, 2006). Our recent retrospective
study found that 15% of severe SNHL cases were ascribed to
congenital CMV infection, and that half of the CMV-associated
SNHL was late-onset (Ogawa et al., 2007). Viral and host factors that
affect the development and progression of diseases caused by
congenital CMV infection remain still unclear, although transplacen-
tal CMV transmission have been elucidated using human placental
biopsy specimens (Fisher et al., 2000; Maidji et al., 2007). Animal
models are generally important for studies on pathogenesis as well as
on prevention and treatment of diseases. Although non-human
primate models can provide critical information on the congenital
infection, the models have limitations in their availability and costsl rights reserved.(Barry et al., 2006). A mouse model based on intracerebral infection
with murine CMV (MCMV) has been useful to understand the
mechanisms of CMV-associated neurological disorders that may
correlate with the progressive events following congenital infection
(Tsutsui et al., 2005). In contrast to MCMV and rat CMV (RCMV),
guinea pig cytomegalovirus (GPCMV) crosses the placenta and causes
infection in utero, which makes GPCMV animal models useful for
studies on the mechanisms of transplacental transmission of CMV as
well as for evaluation of vaccines, antiviral drugs, and passive
antibody to prevent diseases associated with congenital CMV
infection (reviewed in Schleiss, 2002, 2006; Grifﬁths and Walter,
2005; Kern, 2006). We have recently demonstrated congenital CMV-
associated labyrinthitis in a guinea pig model (Katano et al., 2007) in
which vertical infection by GPCMV occurred through the placenta,
and the virus spread to the inner ear through perilymph and neural
routes. Although sequences of some individual genes and establish-
ment of GPCMV-BAC systems were reported previously (Fox and
Schleiss, 1997; McGregor et al., 2004a; Penfold et al., 2003; Schleiss
et al., 1999), the lack of the complete GPCMV genome sequence and
other molecular tools has limited use of the GPCMV models. To more
fully characterize the GPCMV genome, we constructed plasmid
libraries that covered the entire GPCMV genome. During the
characterization of the plasmid libraries, we noticed that an extra
1.6 kb sequence was present in a subset of plasmids that contain the
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purchased from the American Type Culture Collection (ATCC) consist
two types of strains, one containing and the other lacking this 1.6 kb
locus. In this study, we characterized growth properties of these two
strains in cell culture and in animals.
Results
Identiﬁcation of two strains, GPCMV/full and GPCMV/del, in virus stocks
propagated in cell culture
During the process of assembling sequences of a 10 kb region
upstream of IE2 gene homolog, we identiﬁed a 1.6 kb sequence that
was present only in a subset of plasmids that span the same
surrounding sequence.
To examine whether this is a cloning artifact, we designed PCR
using primers P1 and P2 that ampliﬁed a 2.0 kb region containing the
1.6 kb sequence (Fig. 1A, Table 1). The PCR ampliﬁcation yielded both
2.0 kb and 0.4 kb fragments from the GPCMV genomic DNA used for
the preparation of plasmid libraries (Fig.1B, lane 1), indicating that the
virus stock ATCC-P5, which was propagated ﬁve times from the
original ATCC stock in cell culture and used for preparation of the
plasmid libraries, contained two types of strains, one containing and
the other lacking the 1.6 kb sequence.
To conﬁrm the presence of two strains, guinea pig lung ﬁbroblast
(GPL) cells were infected with serially-diluted ATCC-P5 in 96-well
plates, and 10 independent virus clones (CA to CJ) were isolated. These
clones were ampliﬁed twice in GPL cells (CA-P2 to CJ-P2). Analysis of
their DNA by the PCR assay described above indicated that 4 out of theFig. 1. (A) Schematic maps of the GPCMV genome and the 1.6 kb locus. Positions of sites for K
ampliﬁcation of a 2.0 kb region spanning the 1.6 kb region. P5, P6, and F indicate the primers
indicate those used to quantify the amount of GPCMV/del (del). Closed arrows are open readi
and P2 primers. DNA samples were extracted from the following virus stocks: ATCC-P5 (lane
PCR products of GPCMV/full and GPCMV/del, respectively.10 clones had the 1.6 kb sequence, 5 clones lacked it, and 1 clone had
both forms (Fig. 1B, lanes 2–11). It is clear that the ATCC-P5 stock
contained two strains. Hereafter, we call the strain with the 1.6 kb
sequence GPCMV/full and the strain without the sequence GPCMV/
del. Importantly, the SG-P9 stock, which was propagated once in a
guinea pig followed by 9 passages in GPL cells, contained mainly
GPCMV/full (Fig. 1B, lane 12). As described later, the original vial
purchased from ATCC also contained both strains.
Comparison of genome structures of the two strains
To examine the difference in the genome structures between
GPCMV/full and GPCMV/del, DNA samples were prepared from GPL
cells infected with CA-P5 (GPCMV/del) and with CD-P5 (GPCMV/full).
Twenty-one PCR products that cover the entire 233.5 kb genome,
except a couple hundred base pairs at each terminus and a 1.2 kb
region (106,188–107,373) containing 26 direct repeats of a 22-bp
sequence and 8 direct repeats of a 21-bp sequence, were ampliﬁed
from the DNA samples by long PCR (Fig. 2A). Restriction fragment
length polymorphism (RFLP) analysis of the long PCR products did not
identify any detectable differences between two strains other than the
1.6 kb deletion in the “r” fragment of GPCMV/del at this resolution
(Figs. 2B and C).
Analysis of the 1.6 kb locus sequence
There are ﬁve open reading frames (ORFs) with coding capacity of
more than 80 amino acids (a.a.) in the 1.6 kb locus (Fig. 1A). Since the
351 a.a. ORF just leftward the 1.6 kb locus encodes a homolog ofMCMVpnI (K), XbaI (X), and EcoRI (E) are shown. P1 and P2 indicate the primers used for PCR
and probe for quantitative PCR to measure the amount of GPCMV/full (full). P7, P8, and D
ng frames disrupted or deleted due to the 1.6 kb deletion. (B) Conventional PCR using P1
1), CA- to CJ-P2 (lanes 2–11) and SG-P9 (lane 12). Open and closed arrows indicate the
Table 1
Primers, probes, and cycle conditions
Primer/
probe
Sequence (5′ to 3′) Cycle conditions
PCR of the 1.6 kb locus
P1 GTAGGTACCCGCAGGTTTGC 96°C/5 min, 40×[94°C/45s, 63°C/30s,
P2 TTGATCACGGACGACGATAC 72°C/4 min 30s], 72°C/10 min
Detection of GPCMV
GP83F CGACGACGACGATGACGAAAAC 50°C/2 min, 95°C/10 min,
GP83R TCCTCGGTCTCAACGAAGGGTC 50×[95°C/30s, 60°C/1 min]
GP83 FAM-ATCCGAGTTAGGCAGCG-MGB
Detection of actin gene
P3 TGGATCGGCGGCTCTATC 50°C/2 min, 95°C/10 min,
P4 CATCGTACTCCTGCTTGCTGAT 50×[95 °C/30s, 60°C/1 min]
A FAM-CACTCTCCACCTTCC-MGB
Detection of GPCMV/full
P5 ATAAACGTCGCAGTCCAACGTT 50°C/2 min, 95°C/10 min,
P6 CGTCCTTCTTGTGGCATTATACG 50×[95°C/30s, 60°C/30s, 72°C/34s]
F FAM-CACCGTCTTTCATCCGT-MGB
Detection of GPCMV/del
P7 CGTGTATGAAAATGTGTGGACTGA 50°C/2 min, 95°C/10 min,
P8 TAGAAAGGTGCATAATAAACCGTTGA 50×[95°C/30s, 60°C/30s, 72°C/34s]
D FAM-TAGAAACGCCCAGCATC-MGB
RACE
P9 TGCGGCCTGGCATAAGTGTG
P10 ACACTTATGCCAGGCCGCAC
Detection of IE2 transcript
P11 GCTCGGGTTTGATCTGTGAGAT 48°C/30 min, 95°C/10 min,
P12 GCGATATGGCAAACGATGAAC 40×[95°C/15s, 60°C/1 min]
IE FAM-TCTGCAACAGCACTCA-MGB
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g133, respectively. Analysis using FASTA demonstrated that g132 ORF
has sequence similarity with tupaia herpesvirus (THV) t13.1 and some
chemokines, including IL-8, CCL18, and CCL3 (Table 2). However, g132
has no CC- or CXC-motifs, which are typically found in those
chemokines. g132 has also 52% similarity across a 73 a.a. segment
with HCMV UL130. Although g132 may be a positional homolog of
MCMV M131 (mck-1) encoding CC chemokine, it has no discernable
sequence similarity with mck-1. The FASTA analysis did not identify
any meaningful sequence homologs for the other 4 ORFs. BLASTP
(Altschul et al., 1997) analysis also demonstrated that g132 has a weak
similarity with THV t13.1 and IL-8 (data not shown). Other predicted
characteristics of the ORFs are summarized in Table 2.
Comparison of growth in cell culture between GPCMV/full and
GPCMV/del
To examine the difference in growth abilities in vitro between
GPCMV/full and GPCMV/del, titers of extracellular and intracellular
viruses were determined at indicated hours after infection of GPL cells
with the following virus stocks: CA-P4 and CB-P4 representing
GPCMV/del, CD-P4 and SG-P9 representing GPCMV/full (Fig. 3); all
four had similar growth kinetics. In addition, there were no obvious
differences in plaque size among the virus stocks (data not shown).
Thus, the 1.6 kb deletion does not affect the growth of GPCMV in cell
culture in a short term.
Decrease of GPCMV/full in virus stocks after passages in cell culture
To examine the subtle effect of the 1.6 kb deletion on viral growth,
the ratios of GPCMV/full and GPCMV/del in virus stocks after serial
passages of cell-free virus were measured by quantitative PCR assays,
one targeting the junction of the 1.6 kb deletion and the other targetingan internal region of the 1.6 kb sequence (Fig. 4). The proportion of
GPCMV/full in ATCC-P2, second passage from the original vial ATCC,
was 50% and decreased to 15% in the stock after 8 passages from ATCC-
P2. Simplemathematical estimation indicates that the ratio of the virus
yields between GPCMV/full and GPCMV/del in each passage was
1:1.25. On the other hand, the proportion of GPCMV/full in the CD-P2
stock prepared by virus cloning was almost 100%, with no GPCMV/del
emerging after 8 passages in GPL cells. In addition to the quantitative
PCR assay, the conventional PCR amplifying the 2.0 kb region did not
yield any detectable shorter fragment in the stock passaged 8 times
from CD-P2 (data not shown). These results suggest that GPCMV/full
itself is relatively stable but it has a slight disadvantage in growth in
vitro as compared with GPCMV/del. Importantly, using the quantita-
tive PCR assays, we found that 17% of GPCMV in the vial originally
purchased from ATCC was GPCMV/del (data not shown).
To examine whether GPCMV/full and GPCMV/del have any
differences in cell tropism, GPC16, a guinea pig colon adenocarcinoma
cell line with epithelial morphology, which is the only commercially
available non-ﬁbroblast cell line, was infected with the ATCC-P5 stock
at an MOI of 3. The infected GPC16 cells were i) cultured for 4 days, ii)
cultured for 7 days, or iii) cultured for 4 days and then co-cultured
with GPL cells for additional 3 days. We found that in all cases, i) CPE
was not observed, ii) b0.05% of the input GPCMV DNAwas detected in
the infected cells, and iii) GPCMV antigens were not detectable in IFA
using monoclonal antibody against a GPCMV early antigen, indicating
that GPC16 was not permissive to GPCMV growth.
Growth properties of viral stocks containing both GPCMV/full and
GPCMV/del in animals
Before we analyzed the growth of GPCMV/full and GPCMV/del in
animals, we compared susceptibility of 5 inbred guinea pig strains to
GPCMV, since somemouse strains are known to be resistant to MCMV
infection (Scalzo et al., 1990). Five-week old female animals were
inoculated with the ATCC-P5 stock, and sacriﬁced at 6–7 days or 20–
21 days post infection (p.i.). Viral loads in their organs were measured
by the quantitative PCR assays, one targeting GPCMV GP83 gene and
the other targeting the guinea pig β-actin gene. GPCMV DNA was
detectable mainly in spleens at 6–7 days p.i., and mainly in salivary
glands (SG) at 20/21 days p.i. Based on the viral loads in spleens and
SG, there was no signiﬁcant difference in GPCMV susceptibility among
the ﬁve inbred strains (data not shown). The Hartley strain was used
for the rest of the experiments.
Ratios between GPCMV/del and GPCMV/full in organs obtained
from eight guinea pigs infected with the ATCC-P5 stock were analyzed
by the quantitative PCR assays speciﬁc to the viruses with andwithout
the 1.6 kb locus (Fig. 5). The ratios between GPCMV/del and GPCMV/
full were 1:1.7, 1:3.3, 1:10, and 1:130 in livers, spleens, lungs, and
salivary glands, respectively. The results indicate that GPCMV/full
disseminated to spleens 5-fold better than GPCMV/del, since the
proportion of GPCMV/full in the stock used for the animal experi-
ments was 40%. Similarly, GPCMV/full disseminated approximately
200-fold efﬁciently to SG.
Comparison of viral loads in animals infected with GPCMV/full and with
GPCMV/del
Since we cannot exclude the possibility that one of the two virus
types in the ATCC-P5 stock may complement or inhibit the growth of
the other in animals, guinea pigs were also inoculated individually
with the cloned stocks of GPCMV/full and of GPCMV/del to compare
their growth in animals. Purity (N99.99%) of the virus clones used for
the analysis was conﬁrmed by the strain-speciﬁc quantitative PCR
assay. As shown in Fig. 6, GPCMV/del did not disseminate well to lung
and other organs, conﬁrming the experiment with the ATCC-P5 stock
described above.
Fig. 2. Comparison of GPCMV genome structures between GPCMV/full and GPCMV/del. (A) Fragment length, primer sets, and PCR conditions for preparation of PCR fragments “a” to
“u” are shown. (B, C) Examples of HincII- and BanI-digest of fragments “n” to “r” of GPCMV/full (F) and GPCMV/del (D) along with 1 kb and 100 bp DNA ladder (New England Biolabs).
Open and closed arrows indicate the bands that are unique to GPCMV/full and GPCMV/del, respectively.
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To develop an assay for quantiﬁcation of virus-speciﬁc gene
expression in organs, the structure of the IE2 transcript was
determined, since CMV IE2 homologs are generally expressed from
spliced transcripts. For this purpose, we conducted 5′ rapid ampliﬁca-
tion of cDNA ends (RACE) and 3′RACE using primers P9 and P10, which
are located within the IE2 ORF homolog, respectively. A 1.8 kb
fragment and a 0.6 kb fragment were ampliﬁed by the respective
reactions. Sequencing analysis demonstrated that GPCMV IE2 tran-
script consists of 5 exons encoding a 676 a.a. protein (Fig. 7A). A TATA
box is present 25-bp upstream of the transcription start site and a
polyadenylation signal 102-bp downstream from the stop codon in
exon 5 (data not shown). GPCMV IE2 protein has 33% identity (61%
similarity) in a 502 a.a. overlap with HCMV(Merlin) and 28% identity(56% similarity) in a 608 a.a. overlap with MCMV(Smith) ie3.
Phylogenic analysis of exon 5 of the IE2 gene homologs at a protein
level indicates that GPCMV is intermediate between CMVs of rodents
and CMVs of primates rather than within those of rodents (Fig. 7B).
Based on the IE2 gene structure, we established a quantitative
reverse transcription (RT)-PCR assay targeting the junction of the
exons 4 and 5 (Fig. 7A).
Comparison of IE2 transcript abundances in animals infected with
GPCMV/full and with GPCMV/del
Relative amounts of the IE2 transcript per mg of organs of animals
infected with GPCMV/full and GPCMV/del were obtained by quanti-
tative RT-PCR. As shown in Fig. 8A, IE2 transcripts tend to be more
abundant in GPCMV/full-infected animals than in GPCMV/del-
Table 2
Characteristics of the ORFs located in the 1.6 kb locus and those ﬂanking the locus
ORF Length (aa) FASTAa SMARTb SOSUIc
Organismd Gene Identity Similarity
GP128 351 MCMV M128 (ie2) 24% in 295aa 52% in 295aa US22 family [43–345aa.] Soluble
g129 173 Mus musculus Ubiquitin speciﬁc peptidase 16 39% in 46aa 70% in 46aa Low complexity [73–86aa] Soluble
g130 130 – No hit – – No hit Soluble
g131 118 – No hit – – No hit Soluble
THV t13.1 33% in 58aa 60% in 58aa
Bos taurus IL-8 32% in 50aa 70% in 50aa
g132 81 Homo sapiens CCL18 30% in 56aa 63% in 56aa Signal peptides [1–12aa.] transmembrane [5–27aa]
Mus musculus CCL3 29% in 72aa 56% in 72aa
HCMV UL130 30% in 73aa 52% in 73aa
g133 127 – No hit – – Signal peptides [1–19aa] Transmembrane [1–22aa]
g134 227 Homo sapiens JAM3 27% in 97aa 61% in 97aa Transmembrane [13–35, 76–98aa] Transmembrane [12–34, 74–96aa]
a http://fasta.ddbj.nig.ac.jp/top-e.html (matrix: BLOSUM50).
b http://smart.embl-heidelberg.de/ (Schultz et al., 1998).
c http://bp.nuap.nagoya-u.ac.jp/sosui/ (Hirokawa et al., 1998).
d Only the homologs of viral- or mammalian-proteins were listed.
49N. Nozawa et al. / Virology 379 (2008) 45–54infected animals. IE2 transcript levels correlated with viral DNA loads
(Fig. 8B).
Frequent detection of vial antigens in spleen and other organs of animals
infected with GPCMV/full
Immunohistochemical (IHC) examination with g-1 monoclonal
antibody speciﬁc to GPCMV early antigens demonstrated that viral
antigens were detectedmore frequently in spleens of animals infected
with GPCMV/full than in those infected with GPCMV/del (Figs. 9B and
F). GPCMV-infected cells localized around the primary follicle and
inter-follicular zone in the spleen. Hematoxylin and eosin (HE)
staining shows inﬂammatory cell inﬁltration in the Glisson sheath in
the liver of one of CD-P5 (GPCMV/full)-infected animals but not in CA-
P5-infected animals (Figs. 9C and G). IHC indicates the presence of
GPCMV antigen in the inﬂammatory region of the liver of GPCMV/full-
infected animal, suggesting hepatitis associated with GPCMV/full
infection (Fig. 9D).
Discussion
In this study, we identiﬁed a locus of GPCMV genome that may be
essential for efﬁcient virus growth in animals but not in vitro. The
properties we found are related to some observations for HCMV andFig. 3. Growth kinetics of GPCMV in vitro. GPL cells were infected with the following
GPCMV stocks at an MOI of 0.5: CA-P4 (open squares) and CB-P4 (open diamonds)
representing GPCMV/del; CD-P4 (closed circles) and SG-P9 (closed triangles) repre-
senting GPCMV/full. Titers of intracellular and extracellular viruses at indicated time
points were measured in triplicate, and their means are plotted. Standard deviations
(SD) are only shown for the titers at the last time point to simplify the ﬁgure.MCMV. For example, there is a long history of loss of tropisms towards
PBMC and endothelial cells as well as attenuated pathogenicity in
humans after in vitro propagation of clinical isolates of HCMV. Cha et
al. (1996) identiﬁed the loss of N13 kb segment from laboratory
strains. Subsequent many studies demonstrated the relationship of
the attenuated phenotypes with genetic alterations, including dele-
tions and frame-shift mutations (reviewed in Prichard et al., 2001;
Jarvis and Nelson, 2007). Similarly, two strains of rhesus CMV
(RhCMV), the ATCC strain 68.1 and a pathogenic isolate 180.92, have
sequence differences due to genetic rearrangements in the region
similar to HCMV UL129–132 (Rivailler et al., 2006). In the case of
MCMV, propagation of MCMV in vitro led to decreased virulence and
spontaneous deletions that affected viral cell tropism (Cavanaugh et
al., 1996; Misra and Hudson, 1980). Passage of the mixture of GPCMV/
full and GPCMV/del resulted in gradual increases of the proportion of
GPCMV/del. Since GPCMV/del is generated only 1.25-fold of GPCMV/
full in each passage, it is almost impossible to identify such a subtle
difference in the standard one-step growth experiment. Since 8
passages of GPCMV/full in tissue culture did not yield any detectable
deletion in the 1.6 kb locus, it is likely that the locus itself is relatively
stable. There was no long repeated sequence or motif near the ends of
the 1.6 kb locus, although both ends have an identical 4-bp sequence.
Therefore, it is plausible that the 1.6 kb spontaneous deletion may
confer a slight growth advantage on the virus, which would result in a
mixed population after an extended passage in cell culture.Fig. 4. Proportions of GPCMV/full in virus stocks serially passaged in cell culture. One
tenth volume of infected cell culture supernatants were serially passaged every 5 days
in cell culture 8 times from ATCC-P2 and from CD-P2. The copy numbers of GPCMV/full,
GPCMV/del, and total GPCMV in the passaged stocks were measured by quantitative
PCR assays.
Fig. 5. Growth properties of the GPCMV stocks containing both GPCMV/full and GPCMV/del in animals. Guinea pigs (Hartley) were infected i.p. with 106 PFU of the ATCC-P5 stock.
Organs were harvested at 6 or 7 days (n=5) and at 20 or 21 days (n=3) after infection. Virus genome loads per 1×104 cells were measured by the quantitative PCR assays for the GP83
gene and for the guinea pig β-actin gene. Copy numbers of GPCMV/full and GPCMV/del in the virus stock used for infection (A) and those in the organs (B) were measured by the
strain-speciﬁc quantitative PCR assays. Mean and SD of copy numbers of GPCMV/del and GPCMV/full per 1×104 cells were shown with shaded and closed bars, respectively.
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glands of animals infected with the mixed population, there is no
doubt that the 1.6 kb locus is associated with efﬁcient growth in
animals. In addition, the long PCR-RFLP analysis did not ﬁnd anymajor
differences in the genome structure other than the 1.6 kb locus
between GPCMV/full and GPCMV/del, although the resolution of the
analysis is limited. The 1.6 kb locus encodes genes that plausibly may
be required for growth in animals but not in cell culture, as described
below. However, without a marker rescue experiment of the region or
determination of the complete genome sequences of both GPCMV/full
and GPCMV/del, it is impossible to formally exclude the possibility
that a locus genetically linked to but distinct from the 1.6 kb locus is
the determinant of efﬁcient growth in vivo. Although introduction of
the 1.6 kb deletion into GPCMV-BAC could be an ideal approach, so far
efﬁcient growth of wild-type virus preparations derived fromGPCMV-
BAC has been demonstrated only in immunocompromised animals
(McGregor et al., 2004b; McGregor and Schleiss, 2001). It would be
important to ﬁnd appropriate cell types that differ in growth
characteristics of the two strains in vitro. The only guinea pig
epithelial cell line commercially available was not permissive to
GPCMV. The lack of proper reagents to identify guinea pig cell types
limits the use of primary cells prepared from animals. Since a recent
report described a large-scale preparation and in vitro propagation ofFig. 6. Comparison of viral loads in animals infected separately with GPCMV/full and
with GPCMV/del. Guinea pigs were infected i.p. with 106 PFU of GPCMV stocks, GPCMV/
del (n=4) (open triangles) and GPCMV/full (n=3) (closed circles). Their organs were
collected at 6 days after infection. Viral loads per 1x104 cells were obtained by the
quantitative PCR assays for the GP83 gene and for the β-actin gene.endothelial cells from guinea pig hearts (Oxhorn et al., 2002), such
cells would be worthy of further studies on the characterization of the
two GPCMV strains.
The 1.6 kb locus contains ﬁve ORFs at least 80 a.a. in length. Based
on the location in the genome, the region corresponds to M129–
M133 of MCMV, since the ORF next to the 1.6 kb locus is a M128
(ie2) homolog. One of the ORFs, g132, has a homology with
chemokines, such as IL-8, although it has no CC- or CXC-motif.
MCMV M129/131 encodes mck, a CC chemokine, but its similarity
with CC chemokine is restricted to the ﬁrst exon, i.e. M131, and two
types of transcripts, unspliced (mck-1) and spliced (mck-2), were
reported (MacDonald et al., 1997, 1999). Mck mutants resulted in a
low-level viremia, poor dissemination to salivary glands, and
reduced MCMV-associated inﬂammation in livers (Fleming et al.,
1999; Saederup et al., 1999). MCMV M132 encodes a gene (sgg) that
is also required for MCMV growth in salivary glands (Lagenaur et al.,
1994; Manning et al., 1992). Although GPCMV/del had defects similar
to mck- and sgg-mutant viruses, no M129–M132 homologs were
found in the GPCMV 1.6 kb sequence. The Maastricht and England
strains of RCMV also encode homologs (RCK-2/-3 and ECK-2,
respectively) of MCMV mck-2 (Voigt et al., 2005). The M129–133
co-linear portion of the HCMV genome encodes UL128–UL133, the
locus where genetic alterations were reported for laboratory strains
(Cha et al., 1996; Dolan et al., 2004; Murphy et al., 2003). HCMV
UL128 and UL130 contain sequences homologous to CC chemokines
(Hahn et al., 2004; Akter et al., 2003). The HCMV UL128–131 locus is
critical for both epithelial and endothelial cell tropisms (Hahn et al.,
2004; Wang and Shenk, 2005a,b). UL128, UL130 and UL131 encode
glycoproteins respectively (Wang and Shenk, 2005b; Patrone et al.,
2005; Adler et al., 2006); these glycoproteins form a complex with
gH–gL and the complex mediates entry into epithelial and
endothelial cells (Ryckman et al., 2008). Interestingly, g132 has a
weak similarity with HCMV UL130. Since both MCMV M129–133 and
HCMV UL128–131 regions have complex splicing patterns, it will be
critical to determine the precise structures of the genes in the
GPCMV 1.6 kb locus.
Our results may have implications for vaccine development.
Although GPCMV/del grew inefﬁciently in animals, infection of
animals with it led to seroconversion (data not shown). Injection of
a replication-incompetent GPCMV-BAC DNA induced seroconversion
and protection from CMV diseases in guinea pigs (Schleiss et al.,
2006). In addition, a recent study demonstrated that a MCMV strain
that is genetically engineered with a large deletion of several
Fig. 7. Characterization of the GPCMV IE2 gene. (A) Structure of the IE2 transcript. Fragments obtained by 5′RACE using primer P9 and by 3′RACE using P10 primer were sequenced for
determination of the structure of IE2 exons (Ex) and introns. The closed portion encodes the IE2 protein. Positions of primers P11/12 and probe IE for a quantitative RT-PCR assay to
quantify the IE transcript are shown. (B) Phylogenic dendrogram of IE2 exon 5 of betaherpesviruses, including MCMV, RCMV, chimpanzee CMV (CCMV), HCMV, RhCMV, simian CMV
(SCMV), THV, human herpesvirus 6A (HHV6A), HHV6B, and HHV7. GenBank acc. no. of these sequences were U68299, AF232689, AF480884, AY446894, AY186194, U38308,
AF281817, X83413, AF157706, and AF037218, respectively.
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attenuated in vivo was useful as a vaccine in a mouse model (Cicin-
Sain et al., 2007). It would be interesting to see whether prior
infection with GPCMV/del can prevent GPCMV-associated labyrinthi-
tis by superinfected virus in our congenital transmission model
(Katano et al., 2007).
In conclusion, we found that a GPCMV genome locus adjacent to
MCMV M128 (ie2) homolog is required for efﬁcient virus growth in
animals. Further studies will be required to determine which gene
product in the 1.6 kb locus controls the in vivo growth capability of
GPCMV.Fig. 8. (A) Comparison of the amounts of IE2 transcripts. Guinea pigs inoculated i.p. with 106 P
closed circles), and their organs were collected at 6 days after inoculation. Total RNA sample
IE2 transcripts. Detection limit of the IE2 transcripts per mg of the organs in the assay was de
shown. (B) Comparison between viral loads per mg of organs (x-axis) and relative amountsMaterials and methods
Cells, viruses, and animals
Guinea pig lung ﬁbroblasts (GPL, ATCC CCL-158)were cultured in F-
12medium supplementedwith 10% fetal bovine serum (FBS), and after
infection with GPCMV, in F-12 medium supplemented with 2% FBS.
GPCMV strain 22122was purchased fromATCC (VR-682); the attached
product sheet described its passage history as follows: 44 passages in
guinea pig, 3 passages in tissue culture of guinea pig embryo, and one
passage in GPL cells. GPL cells were infected with the original ATCCFU of the GPCMV/del stocks (n=4, open triangles) and with the GPCMV/full stocks (n=3,
s prepared from liver, spleen, and lung of the animals were used to quantify the GPCMV
ﬁned as 1, and amounts of the transcript in each organ relative to the detection limit are
of IE2 transcripts (y-axis) is shown.
Fig. 9. Pathological examination of the organs of the animals infected separatelywith the CD-P5 (GPCMV/full) stock (A–D) andwith the CA-P5 (GPCMV/del) stock (E-H). HE staining of
spleen (A, E) and of liver (C, G), and immunohistochemical (IHC) staining with g-1 monoclonal antibody against GPCMV (B, D, F and H).
52 N. Nozawa et al. / Virology 379 (2008) 45–54stock of GPCMV, and then the infected cells (ATCC-P1) were
propagated by co-culturing with uninfected GPL cells at a ratio of
1:5–1:10 four times to prepare a large stock of cell-free virus (ATCC-
P5). Ten independent virus clones (CA-P1 to CJ-P1)were obtained from
ATCC-P5 by limiting dilution and cell-free viruseswere passaged 2 to 5
times inGPL cells to prepare virus stocks (C#-P2 to C#-P5, #meansA to
J). GPCMV stocks were also prepared from SG of a guinea pig (Hartley
strain) infected with the ATCC-P5 stock. SG were minced, sonicated
brieﬂy, and centrifuged to remove debris. These supernatants were
used for infection of GPL cells, and viral stocks were prepared after
propagation of the cell-free virus 9 times in GPL cells (SG-P9). Guinea
pig colon adenocarcinoma GPC16 cells (ATCC CCL-242) were cultured
in Eagle's Minimal Essential medium supplemented with 10% FBS,
1 mM sodium pyruvate, and 1.5 g/l sodium bicarbonate.
Five-week old female guinea pigs, including 5 inbred strains,
Hartley, Strain-2, Strain-13 (Festing, 1978) (Japan SLC, Inc.), Weiser-Maples and JY-1 (Kitagaki et al., 2005; Chiba et al., 1978) (Tokyo
Laboratory Animals Science Co., Ltd.), were used in this study. Animals
were inoculated intraperitoneally (i.p.) with 106 PFU of GPCMV
propagated in GPL cells. Blood specimens were drawn directly from
heart, and organ specimens, including liver, spleen, kidney, lung, and
salivary gland, were harvested at indicated days after inoculation. All
animal procedures were approved by the Animal Care and Use
Committee of the National Institute of Infectious Diseases (NIID), and
were conducted according to ‘the Guidelines for Animal Experiments
Performed at the NIID’.
Analysis of GPCMV growth in cell culture
Titration of virus stocks was done by a standard plaque assay as
well as by immunostaining of foci of infected cells. For immunostain-
ing, GPL cells were infected with GPCMV stocks in 24- or 12-well
53N. Nozawa et al. / Virology 379 (2008) 45–54plates, and incubated for 2 h. Then, the inocula were replaced with F-
12 medium containing 2% FBS and the cells were cultured for 2–
3 days. The cells were ﬁxed with 4% formaldehyde, permeabilized
with 0.5% TritonX-100, reacted with g-1, a monoclonal antibody
speciﬁc to GPCMV early antigen (Katano et al., 2007), and then reacted
with peroxidase-conjugated goat anti-mouse IgG (DAKO). The signal
was visualized with a buffer containing 3,3′-diaminobenzidine (DAB
substrate, Roche), and foci of the infected cells were counted under a
dissecting scope.
For preparation of intracellular virus stocks, after removal of
culture supernatants, the infected cells were harvested into fresh
medium, freeze-thawed once, sonicated brieﬂy, and then centrifuged
to remove debris.
Construction of plasmid libraries and sequencing
GPCMV genome DNA was puriﬁed from the nucleocapsids of
GPCMV(ATCC-P5)-infected GPL cells as described previously (Straus et
al., 1981). Viral DNA was digested with a restriction enzyme, such as
EcoRI, HindIII, KpnI, BamHI, BglII and XbaI, and the digests were
cloned into pBluescript KSII(+) (Stratagene) to prepare plasmid
libraries. Mapping of the plasmids was done initially by Southern
blotting and by sequencing of the ends of inserts using theM13 and T7
universal primers. Some portions of the GPCMV genome were
sequenced by a primer-walking strategy. A commercial kit (BigDye
Terminator Cycle Sequencing Kit ver. 3.3, PE Applied Biosystems) was
used for sequencing reaction, and the reactions were analyzed in the
ABI PRISM 7500 sequence detection system (PE Applied Biosystems).
Data were assembled and analyzed by using the programs ATGC and
GENETYX (Genetyx Inc., Tokyo, Japan). The nucleotide sequence
determined in this study has been submitted to the GenBank database
and assigned accession number EU496382.
Preparation of DNA and RNA samples
Buffy coat fractions were obtained by separation in Lymphocyte
Separation Medium (Cappel). Liver, spleen, kidney, and lung speci-
mens of guinea pigs were homogenized mechanically using dispo-
sable-pestles in 1.5 ml tubes (1.5 Pellet Pestle, Kontes Glass Co., Japan)
for puriﬁcation of DNA, and using rotor-stator homogenizers com-
bined with 1 mm-diameter zirconia beads (Multi-beads shocker,
Yasuikikai, Japan) for preparation of total RNA. Salivary gland speci-
menswere homogenized using theMulti-beads shocker. DNA samples
were prepared from the homogenized organ specimens, buffy coat
fractions, and GPL cells by using a commercial kit (QIAamp DNA Mini
kit, QIAGEN). Total RNA samples were prepared from the same
materials by using a commercial kit (RNeasy Plus Mini kit, QIAGEN).
Generally 50 μl of total RNA were prepared from around 15 mg of
organ specimens.
Long PCR-RFLP analysis
Viral DNA samples for PCR-RFLP were prepared as described
previously (Igarashi et al., 1993). Brieﬂy, GPCMV-infected cells in a 10-
cm diameter dish were washed once with PBS, scraped into PBS and
recovered by centrifugation. The cell pellets suspended in a buffer
containing 0.1 % Nonident P-40 were incubated for 10 min on ice, and
then nuclei were removed by centrifugation at 1200×g for 5 min. The
supernatant ﬂuid was extracted with phenol/chloroform, and viral
DNA was precipitated in ethanol and suspended in 45 μl of water.
Twenty-one fragments from each strain were ampliﬁed by long PCR
using the primer sets and thermal cycle conditions shown in Fig. 2A.
Fifty microliters of reaction mixture contained 1×buffer, 0.4 mM
dNTP, 0.3 μM primers, 1 U of KOD FX (TOYOBO, Japan), and 0.2 μl of
viral DNA. PCR products were separated on 0.7% agarose gels and
puriﬁed using a commercial kit (MagExtractor-PCR and Gel Clean up-,TOYOBO). Puriﬁed DNA fragments were digested with restriction
enzymes and separated on 2.0% NuSieve (3:1) agarose.
RACE
GPL cells were infected with GPCMV at a multiplicity of infection
(MOI) of 5, and cultured for 3 days or cultured in the presence of
200 μg/ml of cycloheximide for 4 h. Total RNA samples were used
for RT-PCR and RACE. The RACE reactions were done by using a
commercial kit (SMART RACE cDNA Ampliﬁcation Kit, Clontech) as
described in the manufacturer's instructions, with primers P9 and
P10, which are oriented to the 3′ to 5′ and 5′ to 3′ directions,
respectively, in the IE2 ORF (Table 1). RACE products were separated
on agarose gels and puriﬁed using a DNA extraction kit (QIAEXII,
Qiagen). The sequences of the DNA fragments were determined as
described above.
PCR assays
Conventional PCR for detection of the 1.6 kb locuswas done in 25 μl
of reaction mixture containing 1.5 U of PfuI polymerase (Promega),
1×PfuI buffer, 200 μM dNTPs, 0.5 μM of P1 and P2 primers, and DNA
sample. Sequences of the primers and PCR conditions are shown in
Table 1.
The quantitative PCR assay targeting GP83 gene for quantiﬁcation
of GPCMV DNA was performed as described previously (Katano et al.,
2007). To obtain the GPCMV DNA copy numbers in a single cell, copy
numbers of the guinea pig β-actin gene (GenBank acc. no. AF508792)
were determined by quantitative PCR using primers P3 and P4 and
probe A (Table 1). Reaction and cycle conditions were same as that for
the GP83 gene. To quantify the ratio of GPCMV/full and GPCMV/del in
each sample, quantitative PCR assays, one targeting the junction of the
1.6 kb deletion and the other targeting an internal region of the 1.6 kb
sequence, were designed (Fig. 1A). Primers, probes, and the cycle
conditions were shown in Table 1. Their reaction mixture was as GP83
except for using carrier DNA from Escherichia coli instead of from
salmon sperm. The quantitative PCR assays for GPCMV/full and
GPCMV/del detected the expected strain speciﬁcally at sensitivities
similar to that for the GP83 gene (14–16 genome/reaction).
Amounts of transcripts encoding GPCMV IE2 were measured by
quantitative RT-PCR using a commercial kit (TaqMan One-step RT-PCR
Master Mix Reagents Kit, Applied Biosystems). Primers, probe, and
reaction conditions are shown in Table 1. The IE probe used for the
assay targets the junction of IE2 exons 4 and 5. Reactions were
performed in a 50-μl reaction containing 2 μl of total RNA. Reactions in
the absence of RNA and in the absence of reverse transcriptase served
as negative controls. Relative amounts of the IE2 transcripts were
calculated based on threshold PCR cycle numbers, and normalized
with weights of organs used for RNA preparation.
Pathological examination
All organs obtained from sacriﬁced animals were ﬁxed in 10%
buffered formalin. Formalin-ﬁxed specimens were embedded in
parafﬁn, sectioned, and stained with hematoxylin and eosin (HE), as
described previously (Katano et al., 2007). Immunohistochemistry
was performed with MAb g-1 as primary antibody. For the second and
third phase immunostaining reagents, a biotinylated F(ab′)2 fragment
of rabbit anti-mouse immunoglobulin (DAKO) and peroxidase-
conjugated streptavidin (DAKO) were used. DAB was used as a
chromogen and the slides were counterstained with hematoxylin.
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